Company Profiles

driven by the PitchBook Platform

Diasome Pharmaceuticals

Description

Developer of novel and cell targeted therapies designed to treat diabetes and obesity. The company's cell targeted therapies includes research and development of a oral compound, cell receptor targeting, insulin replacement and hepatic (liver) glucose metabolism which are based on new insights of normal glucose metabolism and a novel mechanism of action, along with a nanotechnology-based oral compound for Type 2 diabetes population that enables its clients to have a significant impact in treating obesity and diabetes.

2004

Founded

PRIVATE

Status

Later Stage VC

Latest Deal Type

$30M

Latest Deal Amount

$43.2M

Total Amount Raised

6

Investors

Description

Developer of novel and cell targeted therapies designed to treat diabetes and obesity. The company's cell targeted therapies includes research and development of a oral compound, cell receptor targeting, insulin replacement and hepatic (liver) glucose metabolism which are based on new insights of normal glucose metabolism and a novel mechanism of action, along with a nanotechnology-based oral compound for Type 2 diabetes population that enables its clients to have a significant impact in treating obesity and diabetes.

Website:

www.diasome.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals
Biotechnology

Primary Office

10000 Cedar Avenue Suite 6 Cleveland, OH 44106United States +1 (216) 444-7110
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Diasome Pharmaceuticals's full profile, request a free trial.

Diasome Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Diasome Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Diasome Pharmaceuticals Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Black Beret Life SciencesVenture CapitalMinority000 0000000 0000
Devon Park BioventuresVenture CapitalMinority000 0000000 0000
L2 PharmaMinority000 0000000 0000
McDonald's VenturesCorporate Venture CapitalMinority000 0000000 0000
Medicxi VenturesVenture CapitalMinority000 0000000 0000
Black Beret Life Sciences Venture Capital
Devon Park Bioventures Venture Capital
L2 Pharma
McDonald's Ventures Corporate Venture Capital
Medicxi Ventures Venture Capital

Diasome Pharmaceuticals Executive Team (3)

NameTitleBoard
Seat
Contact
Info
Robert GehoChief Executive Officer, Co-Founder & Board Member
Helga KautskyChief Financial Officer
W. Geho Ph.DCo-Founder, Chief Scientific Officer & Board Member
Robert Geho Chief Executive Officer, Co-Founder & Board Member
Helga Kautsky Chief Financial Officer
W. Geho Ph.D Co-Founder, Chief Scientific Officer & Board Member

Diasome Pharmaceuticals Board Members (7)

NameRepresentingRoleSinceContact
Info
Frank McCaneySelfBoard Member000 0000
Guiseppe ZoccoSelfBoard Member000 0000
Michèle Ollier MDMedicxi VenturesCo-Founder & Partner000 0000
Richard Caruso Ph.DSelfChairman of the Board000 0000
Robert GehoDiasome PharmaceuticalsChief Executive Officer, Co-Founder & Board Member000 0000
Frank McCaney Board Member Self
Guiseppe Zocco Board Member Self
Michèle Ollier MD Co-Founder & Partner Medicxi Ventures
Richard Caruso Ph.D Chairman of the Board Self
Robert Geho Chief Executive Officer, Co-Founder & Board Member Diasome Pharmaceuticals
Request full access to PitchBook